EPB41L4B

EPB41L4B (Lulu2/Ehm2) is a FERM-domain scaffold protein that organizes the apical circumferential actomyosin belt and modulates cell-cell adhesion in epithelial cells. It localizes to apical cell-cell junctions, where it directly binds and activates p114RhoGEF to stimulate RhoA–ROCK signaling; this activation is negatively regulated by aPKC phosphorylation of its FERM-adjacent domain and is recruited to junctions by the CRB3 complex via its FERM-binding domain (PMID:22006950, PMID:22790195, PMID:26217006). CRB3-dependent amphiregulin secretion and endocytic trafficking require EPB41L4B (PMID:30440051). The Ehm2/1 splice isoform, which is confined to the plasma membrane, stabilizes E-cadherin by inhibiting its ubiquitination, thereby suppressing epithelial-to-mesenchymal transition and cell invasion (PMID:30816447, PMID:36422008).

1. 2006 Medium

   Initial functional characterization showed EPB41L4B participates in cell-matrix adhesion, as its overexpression reduced collagen IV adhesion in prostate cancer cells, linking the FERM-domain protein to adhesion regulation.

   Evidence Overexpression and RNAi in prostate cancer cells with collagen IV adhesion assay

   PMID:16927306

   Open questions at the time

   • No molecular target or binding partner identified
   • Whether effects are direct or via downstream signaling unknown
2. 2010 Medium

   EPB41L4B knockdown reduced MMP-9 expression and invasion in breast cancer cells, establishing a link between EPB41L4B and extracellular matrix remodeling during tumor invasion.

   Evidence Ribozyme knockdown in breast cancer cells with invasion assays and MMP-9 zymography

   PMID:21047774

   Open questions at the time

   • Whether MMP-9 regulation is transcriptional or post-transcriptional not determined
   • No mechanism connecting FERM domain to MMP-9 expression
3. 2011 High

   The central mechanistic question—how does EPB41L4B maintain epithelial architecture—was answered by demonstrating that it directly binds and activates p114RhoGEF at apical junctions, with aPKC phosphorylation of the FERM-adjacent domain serving as a negative regulator.

   Evidence Reciprocal co-immunoprecipitation, RNAi phenotyping, in vitro kinase assay with phospho-mutants, immunofluorescence in epithelial cells

   PMID:22006950

   Open questions at the time

   • Structural basis of FERM-adjacent domain phosphorylation by aPKC unresolved
   • Whether other kinases also regulate this interaction unknown
4. 2012 High

   Quantitative biochemistry confirmed that EPB41L4B directly enhances GEF catalytic activity of p114RhoGEF, establishing it as a bona fide allosteric activator rather than merely a co-localizing scaffold.

   Evidence In vitro GEF activity assay with purified components, RNAi, and co-immunoprecipitation

   PMID:22790195

   Open questions at the time

   • Whether FERM domain alone is sufficient for GEF activation not tested
   • No structural model of the activation complex
5. 2015 High

   The upstream recruitment mechanism was resolved: CRB3A recruits both EPB41L4B and p114RhoGEF to the cell periphery through its cytoplasmic tail, placing the CRB3–EPB41L4B–p114RhoGEF axis as a coherent pathway driving circumferential actomyosin belt formation via ROCK1/2.

   Evidence Ectopic CRB3A expression in HeLa cells, RhoA G-LISA, reciprocal co-immunoprecipitation, ROCK inhibitor epistasis

   PMID:26217006

   Open questions at the time

   • Whether Patj/Pals1 complex members are required for EPB41L4B recruitment not addressed
   • Relative contribution of CRB3 versus other polarity cues in native epithelia unclear
6. 2018 Medium

   Beyond cytoskeletal regulation, EPB41L4B was shown to be required for CRB3-dependent amphiregulin secretion and regulation of endosome size, expanding its role to vesicular trafficking and growth factor signaling.

   Evidence siRNA knockdown in mammary epithelial cells, amphiregulin ELISA, confocal endosome imaging, CRB3 FERM-binding domain deletion mutants

   PMID:30440051

   Open questions at the time

   • Mechanism by which EPB41L4B regulates endosome size not determined
   • Whether amphiregulin secretion requires RhoA activation or a parallel pathway unknown
   • Single lab observation
7. 2019 Medium

   Functional divergence of EPB41L4B splice isoforms was established: plasma membrane–restricted Ehm2/1 promotes epithelial identity (E-cadherin up, Snail1 down), while Ehm2/2, which also localizes to the cytoplasm, promotes mesenchymal features.

   Evidence Isoform-specific overexpression and knockdown in A549 cells, immunofluorescence localization, Western blot for EMT markers

   PMID:30816447

   Open questions at the time

   • Structural determinants of isoform-specific localization not mapped
   • Whether opposing EMT effects act through the same p114RhoGEF pathway unknown
8. 2022 Medium

   The mechanism by which Ehm2/1 stabilizes epithelial identity was pinpointed: it co-localizes with and stabilizes E-cadherin at the plasma membrane by inhibiting E-cadherin ubiquitination, directly linking EPB41L4B to post-translational control of adherens junctions.

   Evidence Co-localization immunofluorescence, cycloheximide chase half-life assay, ubiquitination assay in MCF-7 cells

   PMID:36422008

   Open questions at the time

   • The E3 ligase whose activity is blocked by Ehm2/1 not identified
   • Whether E-cadherin stabilization requires FERM domain or a distinct domain unknown
   • Single lab; no reciprocal validation of direct E-cadherin binding

• Key open questions include the structural basis of EPB41L4B's allosteric activation of p114RhoGEF, the identity of the E3 ubiquitin ligase it antagonizes at E-cadherin, the molecular determinant governing isoform-specific localization, and whether its RhoA-dependent and E-cadherin-stabilizing functions represent parallel or convergent pathways.
• No crystal structure or cryo-EM model of EPB41L4B or its complexes
• E3 ligase counterpart for E-cadherin ubiquitination not identified
• Isoform-specific domain mapping not performed
• In vivo genetic models (knockout mouse) not reported in the timeline